Literature DB >> 21559925

[Endometrial carcinoma].

K Engelhard1.   

Abstract

Magnetic resonance imaging (MRI) is the method of choice in staging endometrial cancer. Using MRI early tumor invasion (stage IA) can be differentiated from a deep tumor growth (stage IB) of the myometrium with reported sensitivities of 85-95%.Tumor invasion of the uterine cervix can be depicted with a sensitivity of 80% and specificity of 96%. In demonstrating lymph node metastases MRI shows a sensitivity of 50%, a specificity of 95% and and accuracy of 90%. These diagnostic criteria are decisive for the choice of therapy procedures. So a simple hysterectomy will be performed in early stage IA disease while an extended surgical procedure with pelvic lymphadenectomy and radiotherapy will be considered in advanced stages IB and II disease. Vaginal ultrasound shows lower values in tumor staging with accuracies of 73-95%. Staging accuracies of computed tomography also show lower results with 61-76%. For planning radiotherapy and detection of cancer recurrence MRI is the most valuable tool.

Entities:  

Mesh:

Year:  2011        PMID: 21559925     DOI: 10.1007/s00117-010-2116-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  19 in total

Review 1.  Imaging of uterine cancer.

Authors:  Oguz Akin; Svetlana Mironov; Neeta Pandit-Taskar; Lucy E Hann
Journal:  Radiol Clin North Am       Date:  2007-01       Impact factor: 2.303

2.  Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging.

Authors:  K Kinkel; R Forstner; F M Danza; L Oleaga; T M Cunha; A Bergman; J O Barentsz; C Balleyguier; B Brkljacic; J A Spencer
Journal:  Eur Radiol       Date:  2009-02-05       Impact factor: 5.315

3.  Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.

Authors:  Gigin Lin; Koon-Kwan Ng; Chee-Jen Chang; Jiun-Jie Wang; Kung-Chu Ho; Tzu-Chen Yen; Tzu-I Wu; Chun-Chieh Wang; Yu-Ruei Chen; Yu-Ting Huang; Shu-Hang Ng; Shih-Ming Jung; Ting-Chang Chang; Chyong-Huey Lai
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

Review 4.  Imaging of endometrial adenocarcinoma.

Authors:  T D Barwick; A G Rockall; D P Barton; S A Sohaib
Journal:  Clin Radiol       Date:  2006-07       Impact factor: 2.350

Review 5.  Imaging the endometrium: disease and normal variants.

Authors:  K M Nalaboff; J S Pellerito; E Ben-Levi
Journal:  Radiographics       Date:  2001 Nov-Dec       Impact factor: 5.333

6.  Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.

Authors:  Subir Nag; Higinia Cardenes; Silvia Chang; Indra J Das; Beth Erickson; Geoffrey S Ibbott; Jessica Lowenstein; Joye Roll; Bruce Thomadsen; Mahesh Varia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

7.  Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma.

Authors:  Hyun Hoon Chung; Soon-Beom Kang; Jeong Yeon Cho; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Seung Hyup Kim; Hyo-Pyo Lee
Journal:  Gynecol Oncol       Date:  2006-11-13       Impact factor: 5.482

8.  MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion.

Authors:  Yoshifumi Nakao; Masatoshi Yokoyama; Koichi Hara; Yasuko Koyamatsu; Makio Yasunaga; Yasuhiro Araki; Yukiko Watanabe; Tsuyoshi Iwasaka
Journal:  Gynecol Oncol       Date:  2006-02-15       Impact factor: 5.482

9.  Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning.

Authors:  Riccardo Manfredi; Paoletta Mirk; Giulia Maresca; Pasquale A Margariti; Antonia Testa; Gian Franco Zannoni; Deborah Giordano; Giovanni Scambia; Pasquale Marano
Journal:  Radiology       Date:  2004-03-18       Impact factor: 11.105

Review 10.  Staging of carcinoma of the uterine cervix and endometrium.

Authors:  Takashi Koyama; Ken Tamai; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-01-12       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.